AIM: To assess the efficiency and safety of radiofrequency-assisted hepatectomy in @entity1 with @entity157 ( @entity157 ) and @entity82 . METHODS: From January 2010 to December 2013, 179 @entity1 with @entity157 and @entity82 were recruited for this retrospective study. Of these, 100 @entity1 who received radiofrequency-assisted hepatectomy (RF+ group) were compared to 79 @entity1 who had hepatectomy without ablation (RF- group). The primary endpoint was intraoperative @entity190 . The secondary endpoints included liver function, @entity260 , mortality, and duration of hospital stay. RESULTS: The characteristics of the two groups were closely matched. The Pringle maneuver was not used in the RF+ group. There was significantly less median intraoperative @entity190 in the RF+ group (300 vs 400 mL, P = 0.01). On @entity773 , median @entity3929 aminotransferase was significantly higher in the RF+ group than in the @entity773 : 348.5 vs 245.5, P = 0.01; POD 5: 112 vs 82.5, P = 0.00), but there was no significant difference between the two groups on POD 3 (260 vs 220, P = 0.24). The median AST was significantly higher in the RF+ group on @entity773 (446 vs 268, P = 0.00), but there was no significant difference between the two groups on POD 3 and 5 (POD 3: 129.5 vs 125, P = 0.65; POD 5: 52.5 vs 50, P = 0.10). Overall, the rate of @entity260 was roughly the same in these two groups (28.0% vs 17.7%, P = 0.11) except that post hepatectomy @entity1578 was far more common in the RF+ group than in the RF- group (6% vs 0%, P = 0.04). CONCLUSION: Radiofrequency-assisted hepatectomy can reduce intraoperative @entity190 during liver resection effectively. However, this method should be used with caution in @entity1 with concomitant @entity82 because it may cause severe @entity409 and @entity1578 .

Efficiency and safety of radiofrequency-assisted hepatectomy for XXXX with @entity82 : A single-center retrospective cohort study.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity82 :: ('MESH:D005355', 'Disease') :: ['cirrhosis'] @entity190 :: ('MESH:D006473', 'Disease') :: ['blood loss'] @entity773 :: ('79585', 'Gene') :: ['postoperative days (POD) 1 and 5', 'POD 1', 'RF- group (POD 1'] @entity409 :: ('MESH:D008107', 'Disease') :: ['liver damage'] @entity260 :: ('MESH:D011183', 'Disease') :: ['postoperative complications'] @entity1578 :: ('MESH:D017093', 'Disease') :: ['liver failure'] @entity3929 :: ('D000409', 'Chemical') :: ['alanine'] @entity157 :: ('MESH:D006528', 'Disease') :: ['HCC', 'hepatocellular carcinoma']
@entity157 :: (MESH:D006528,Disease) :: ['hepatocellular carcinoma']
